A network of up to five new diagnostic facilities are being set up in the UK by Rutherford Health for private and NHS patients.
It has struck a £55m development framework agreement with investors Equitix Ltd, a developer and long-term fund manager of core infrastructure assets in the UK and Europe.
Centres will provide a variety of diagnostics services including positron emission tomography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and X-ray.
Equitix will have a right of first refusal in respect of the development and funding of a further five centres beyond the initial five.
Rutherford said it had agreed ‘with an NHS trust in England’ to create the first facility, but has not announced where this will be.
Its chief executive Mike Moran said: ‘The demand for diagnostic capability in the NHS, and private sector, has increased significantly over the last five years with demand outstripping supply year on year. The agreement with Equitix will enable Rutherford Diagnostics to meet the rising demand for diagnostic clinical services.’
Equitix has over £6bn of assets under management. It has invested in healthcare assets since its inception in 2007 and healthcare is now its largest sector for investment, representing over 39% of its total portfolio.